Voyager Selects Gene Therapy Candidate for Huntington’s Clinical Trials – Huntington’s Disease News
|
Voyager Selects Gene Therapy Candidate for Huntington's Clinical Trials
Huntington’s Disease News Voyager Therapeutics has a new candidate for the treatment of Huntington's disease. The selected gene therapy is called VY-HTT01 and aims to prevent the production of protein from the mutant huntingtin gene (HTT). The compound is now undergoing … |
